Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer

MLA

Sarah Collica, et al. “Combining Prostate Health Index Density, Magnetic Resonance Imaging and Prior Negative Biopsy Status to Improve the Detection of Clinically Significant Prostate Cancer.” BJU International, vol. 121, Jan. 2018, pp. 619–26. EBSCOhost, https://doi.org/10.1111/bju.14098.

APA

Sarah Collica, Christian P. Pavlovich, Lori J. Sokoll, Arnav Srivastava, Jeffrey J. Tosoian, Alan W. Partin, Allen Young, Kamyar Ghabili, Sasha C. Druskin, Ashley E. Ross, Katarzyna J. Macura, & H. Ballentine Carter. (2018). Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer. BJU International, 121, 619–626. https://doi.org/10.1111/bju.14098

Chicago

Sarah Collica, Christian P. Pavlovich, Lori J. Sokoll, Arnav Srivastava, Jeffrey J. Tosoian, Alan W. Partin, Allen Young, et al. 2018. “Combining Prostate Health Index Density, Magnetic Resonance Imaging and Prior Negative Biopsy Status to Improve the Detection of Clinically Significant Prostate Cancer.” BJU International 121 (January): 619–26. doi:10.1111/bju.14098.